Search Page

1

Cite

Share

Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma.

Vicha A, Taieb D, Pacak K. Vicha A, et al. Endocr Relat Cancer. 2014 May 8;21(3):R261-77. doi: 10.1530/ERC-13-0398. Print 2014 Jun. Endocr Relat Cancer. 2014. PMID: 24500761 Free PMC article. Review.

Cite

Share

2

Cite

Share

Targeting PI3K/mTOR signaling exerts potent antitumor activity in pheochromocytoma in vivo.

Lee M, Minaskan N, Wiedemann T, Irmler M, Beckers J, Yousefi BH, Kaissis G, Braren R, Laitinen I, Pellegata NS. Lee M, et al. Endocr Relat Cancer. 2017 Jan;24(1):1-15. doi: 10.1530/ERC-16-0324. Epub 2016 Nov 3. Endocr Relat Cancer. 2017. PMID: 27811202

Cite

Share

3

Cite

Share

Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.

Sadowski SM, Boufraqech M, Zhang L, Mehta A, Kapur P, Zhang Y, Li Z, Shen M, Kebebew E. Sadowski SM, et al. Oncotarget. 2015 Jul 20;6(20):18038-49. doi: 10.18632/oncotarget.3833. Oncotarget. 2015. PMID: 25945839 Free PMC article.

Cite

Share

4

Cite

Share

High expression of mTOR signaling in granulomatous lesions is not predictive for the clinical course of sarcoidosis.

Pizzini A, Bacher H, Aichner M, Franchi A, Watzinger K, Tancevski I, Sonnweber T, Mosheimer-Feistritzer B, Duftner C, Zelger B, Pallua J, Sprung S, Weichhart T, Zelger B, Weiss G, Löffler-Ragg J. Pizzini A, et al. Respir Med. 2021 Jan 5;177:106294. doi: 10.1016/j.rmed.2020.106294. Online ahead of print. Respir Med. 2021. PMID: 33485108 Free article.

Cite

Share

5

Cite

Share

Succinate-Dehydrogenase Deficient Paragangliomas/Pheochromocytomas: Genetics, Clinical Aspects and Mini- Review.

Rusyn L, Kohn B. Rusyn L, et al. Pediatr Endocrinol Rev. 2017 Mar;14(3):312-325. doi: 10.17458/per.vol14.2017.RK.succinatedehydrogenase. Pediatr Endocrinol Rev. 2017. PMID: 28508602 Review. No abstract available.

Cite

Share

6

Cite

Share

(68)Ga-DOTATOC PET and gene expression profile in patients with neuroendocrine carcinomas: strong correlation between PET tracer uptake and gene expression of somatostatin receptor subtype 2.

Olsen IH, Langer SW, Federspiel BH, Oxbøl J, Loft A, Berthelsen AK, Mortensen J, Oturai P, Knigge U, Kjær A. Olsen IH, et al. Am J Nucl Med Mol Imaging. 2016 Jan 28;6(1):59-72. eCollection 2016. Am J Nucl Med Mol Imaging. 2016. PMID: 27069766 Free PMC article.

Cite

Share

7

Cite

Share

Genetics, diagnosis, and management of medullary thyroid carcinoma and pheochromocytoma/paraganglioma.

Moraitis AG, Martucci VL, Pacak K. Moraitis AG, et al. Endocr Pract. 2014 Feb;20(2):176-87. doi: 10.4158/EP13268.RA. Endocr Pract. 2014. PMID: 24449662 Review.

Cite

Share

8

Cite

Share

Strategic Chemotherapy for Pheochromocytoma?

Ghayee HK. Ghayee HK. Endocrinology. 2015 Nov;156(11):3880-1. doi: 10.1210/en.2015-1802. Endocrinology. 2015. PMID: 26474362 No abstract available.

Cite

Share

9

Cite

Share

Hypoxia Pathway Mutations in Pheochromocytomas and Paragangliomas.

Amorim-Pires D, Peixoto J, Lima J. Amorim-Pires D, et al. Cytogenet Genome Res. 2016;150(3-4):227-241. doi: 10.1159/000457479. Epub 2017 Feb 24. Cytogenet Genome Res. 2016. PMID: 28231563 Free article. Review.

Cite

Share

10

Cite

Share

The mTORC1 Complex Is Significantly Overactivated in SDHX-Mutated Paragangliomas.

Oudijk L, Papathomas T, de Krijger R, Korpershoek E, Gimenez-Roqueplo AP, Favier J, Canu L, Mannelli M, Rapa I, Currás-Freixes M, Robledo M, Smid M, Papotti M, Volante M. Oudijk L, et al. Neuroendocrinology. 2017;105(4):384-393. doi: 10.1159/000455864. Epub 2017 Jan 26. Neuroendocrinology. 2017. PMID: 28122379 Free article.

Cite

Share